Results 161 to 170 of about 41,706 (206)

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment. [PDF]

Front Public Health
Liang J, Zhang Q, Li Y, Wang L.
europepmc   +1 more source

Guillain-Barré Syndrome After Inactivated Poliovirus Vaccination: A Rare Clinical Case Report. [PDF]

Ann Med Surg (Lond)
Bereda G.
europepmc   +1 more source

Post-Polio Syndrome: Impact of Humoral Immune Deficiencies, Poliovirus Neutralizing Antibodies, Vitamin D Deficiency. [PDF]

Vaccines (Basel)
Toniolo A, Chumakov K, Federico G, Maccari G, Genoni A, Saba A, Nauti A, Bono G, Molteni F, Monaco S.   +9 more
europepmc   +1 more source

The Emerging Role of Oncolytic Virotherapy in Glioblastoma Management. [PDF]

Cancers (Basel)
Nizamutdinov D, Sentmanat A, Tong J, Qi X, Pan Y, Qi D, Wu E, Huang JH.   +7 more
europepmc   +1 more source

Visualization of the Evolution and Transmission of Circulating Vaccine-Derived Poliovirus (cVDPV) Outbreaks in the African Region. [PDF]

Bio Protoc
Owuor CD, Tesfaye B, Wakem AYD, Kabore S, Ikeonu CO, Doussoh MEFGE, Sigala PEMB, Ibrahim II, Jimoh A, Ndumba I, Khumalo J, Oviaesu DO, Kipchirchir C, Gathenji C, Kipterer J, Touray K, Abdullahi H, Rankin K, Diop OM, Chia JE, Modjirom N, Ahmed JA, Kfutwah AKW.   +22 more
europepmc   +1 more source

Oncolytic Virus Therapies in Malignant Gliomas: Advances and Clinical Trials. [PDF]

Cancers (Basel)
Yang R, Hedberg J, Montagano J, Seals M, Puri S.   +4 more
europepmc   +1 more source

Redefining High-Risk and Mobile Population in Pakistan Polio Eradication Program; 2024. [PDF]

Vaccines (Basel)
Sodhar IA, Mehraj J, Hussaini AS, Ahmed S, Shaikh AA, Zardari AA, Sahitia S, Rasool S, Khowaja A, Stuckey EM.   +9 more
europepmc   +1 more source

Binding of Glycyl-tRNA synthetase to Mengovirus RNA stimulates translation. [PDF]

Nucleic Acids Res
Droß F, Gödert T, Fuchshuber SA, Nachev DV, Andreev DE, Fricke M, Ritsch M, Gerresheim GK, Repp S, Noe Y, Rossbach O, Marz M, Barth P, Goesmann A, Linne U, Weber A, Kracht M, Shatsky IN, Niepmann M.   +18 more
europepmc   +1 more source

Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial. [PDF]

Lancet Infect Dis
Mercer LD, Seña AC, Colgate ER, Crothers JW, Wright PF, Al-Ibrahim M, Tritama E, Vincent A, Mainou BA, Zhang Y, Konopka-Anstadt J, Bandyopadhyay AS, Fix A, Konz JO, Gast C.   +14 more
europepmc   +1 more source